Skip to content

Pfizer Covid Shot Seems Protective for Children Under Five in Early Data

  • Companies to approach US regulators for clearance this week
  • Three doses were 80% effective in an early review of 10 cases
Video player cover image
WATCH: Pfizer-BioNTech’s Covid-19 vaccine is safe for kids under age 5, says Johns Hopkins Bloomberg School of Public Health’s Dr. William Moss.Source: Quicktake
Updated on

Pfizer Inc. and BioNTech SE said their Covid vaccine was highly effective and prompted a strong immune response in children under age 5, based on early results from a trial that is likely to pave the way for infants and toddlers to finally get immunized.

A three-dose regimen was 80.3% effective in a preliminary finding based on 10 infections in children ages 6 months through 4 years old, the vaccine partners said in a statement on Monday. A formal analysis will be done once 21 children are infected, as the study was designed, and final efficacy data will be shared when available.